The U.S. Supreme Court issued a ruling Thursday that struck down college affirmative action programs. The Court issued rulings in Students for Fair Admissions v. Harvard and Students for Fair Admissions v. University of North Carolina, twin cases that sought the prohibition of limited consideration of an applicant’s race or ethnic background in the higher education admissions process. In the decision, the court ruled that both programs violate the Equal Protection Clause of the 14th Amendment of the Constitution. The Court effectively overturned previous rulings in 1978 and 2003 that upheld a

The U.S. Supreme Court issued a ruling Thursday that struck down college affirmative action programs. The Court issued rulings in Students for Fair Admissions v. Harvard and Students for Fair Admissions v. University of North Carolina, twin cases that sought the prohibition of limited consideration of an applicant’s race or ethnic background in the higher education admissions process. In the decision, the court ruled that both programs violate the Equal Protection Clause of the 14th Amendment of the Constitution. The Court effectively overturned previous rulings in 1978 and 2003 that upheld a

The U.S. Supreme Court issued a ruling Thursday that struck down college affirmative action programs. The Court issued rulings in Students for Fair Admissions v. Harvard and Students for Fair Admissions v. University of North Carolina, twin cases that sought the prohibition of limited consideration of an applicant’s race or ethnic background in the higher education admissions process. In the decision, the court ruled that both programs violate the Equal Protection Clause of the 14th Amendment of the Constitution. The Court effectively overturned previous rulings in 1978 and 2003 that upheld a

The U.S. Supreme Court issued a ruling Thursday that struck down college affirmative action programs. The Court issued rulings in Students for Fair Admissions v. Harvard and Students for Fair Admissions v. University of North Carolina, twin cases that sought the prohibition of limited consideration of an applicant’s race or ethnic background in the higher education admissions process. In the decision, the court ruled that both programs violate the Equal Protection Clause of the 14th Amendment of the Constitution. The Court effectively overturned previous rulings in 1978 and 2003 that upheld a

Health care providers and staff using telehealth in their practices – or who would like to – will learn about the latest innovations and developments in this evolving branch of medical care at SIU Medicine’s 2023 Telehealth Conference on Wednesday, August 30. The all-day event can be attended virtually or in person at Memorial Learning Center’s MG Nelson Family Auditorium, 228 W. Miller St. in Springfield.

Health care providers and staff using telehealth in their practices – or who would like to – will learn about the latest innovations and developments in this evolving branch of medical care at SIU Medicine’s 2023 Telehealth Conference on Wednesday, August 30. The all-day event can be attended virtually or in person at Memorial Learning Center’s MG Nelson Family Auditorium, 228 W. Miller St. in Springfield.

Senator Dick Durbin held a news conference at SIU's Simmons Cancer Institute to discuss the shortage of life-saving drugs for cancer patients. Last month, Durbin urged the FDA to use the agency’s authority to immediately address the ongoing shortage.

Senator Dick Durbin held a news conference at SIU's Simmons Cancer Institute to discuss the shortage of life-saving drugs for cancer patients. Last month, Durbin urged the FDA to use the agency’s authority to immediately address the ongoing shortage.

Senator Dick Durbin held a news conference at SIU's Simmons Cancer Institute to discuss the shortage of life-saving drugs for cancer patients. Last month, Durbin urged the FDA to use the agency’s authority to immediately address the ongoing shortage.

Senator Dick Durbin held a news conference at SIU's Simmons Cancer Institute to discuss the shortage of life-saving drugs for cancer patients. Last month, Durbin urged the FDA to use the agency’s authority to immediately address the ongoing shortage.